Avalon Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10M Buy
41,035
+438
+1% +$102K 0.69% 37
2025
Q4
$8.4M Sell
40,597
-281
-0.7% -$55.6K 0.54% 40
2025
Q3
$7.58M Buy
40,878
+136
+0.3% +$23.3K 0.49% 42
2025
Q2
$6.22M Sell
40,742
-7,162
-15% -$1.1M 0.46% 44
2025
Q1
$7.94M Sell
47,904
-2,743
-5% -$429K 0.63% 40
2024
Q4
$7.32M Sell
50,647
-2,667
-5% -$413K 0.52% 43
2024
Q3
$8.64M Sell
53,314
-796
-1% -$127K 0.64% 38
2024
Q2
$7.91M Sell
54,110
-1,653
-3% -$246K 0.63% 38
2024
Q1
$8.82M Sell
55,763
-1,242
-2% -$198K 0.72% 39
2023
Q4
$8.93M Buy
57,005
+12
+0% +$1.84K 0.82% 38
2023
Q3
$8.88M Sell
56,993
-727
-1% -$120K 0.88% 37
2023
Q2
$9.55M Sell
57,720
-1,422
-2% -$230K 0.86% 40
2023
Q1
$9.17M Buy
+59,142
New +$9.55M 0.91% 38

Other funds holding JNJ

Avalon Trust's JNJ Position: Q1 2026 in Review

Avalon Trust increased its Johnson & Johnson (JNJ) stake by 1.1% in Q1 2026, buying an estimated $102K and bringing the position to 41,035 shares worth $10M. The position accounts for 0.69% of the portfolio, ranked #37.

Avalon Trust first reported a position in JNJ in Q1 2023 and has held it in 13 quarters since. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Avalon Trust held 41,035 shares of Johnson & Johnson worth $10M as of Q1 2026.
  • Avalon Trust bought 438 Johnson & Johnson shares in Q1 2026, an estimated $102K.
  • Johnson & Johnson made up 0.69% of Avalon Trust's portfolio in Q1 2026, its #37 holding.
  • Avalon Trust first reported a position in Johnson & Johnson in Q1 2023 and has held it in 13 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.